Oxidized LDL-containing immune complexes induce Fc gamma receptor I- mediated mitogen-activated protein kinase activation in THP-1 macrophages

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 7, 1999, Pages 1600-1607

  Huang, Yan ^b   Jaffa, Ayad ^b   Koskinen, Sinikka ^b   Takei, Akira ^b   Lopes Virella, Maria F ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NONE

Author keywords

Fc gamma receptor; Immune complex; Mitogen activated protein kinase; Oxidized LDL

Indexed keywords

FC RECEPTOR; LOW DENSITY LIPOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; ATHEROGENESIS; CROSS LINKING; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LIPID OXIDATION; MACROPHAGE ACTIVATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0033000417     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.7.1600     Document Type: Article

References (45)

1. Szondy E, Lengyel E, Mezey Z, Fust G, Gero S. Occurrence of anti-low density lipoprotein antibodies and circulating immune complexes in aged subjects. Mech Ageing Dev. 1985;29:117-123.
2. Boullier A, Hamon M, Walters-Laporte E, Martin-Nizart F, Mackereel R, Fruchart J-C, Bertrand M, Duriez P. Detection of autoantibodies against oxidized LDL and of IgG-bound LDL in patients with coronary heart disease. Clin Chim Acta. 1995;238:1-10.
3. Salonen JT, Yla-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, Nyyssonen K, Palinski W, Witztum JL. Autoantibody against oxidized LDL and progression of carotid atherosclerosis. Lancet. 1992;339: 883-887.
4. Mironova M, Lopes-Virella MF, Virella G. Isolation and characterization of human anti-oxidized LDL autoantibodies. Arterioscler Thromb Vasc Biol. 1996;16:222-229.
5. Maggi E, Chiesa R, Melissano G, Castellano R, Astore D, Grossi A, Finardi G, Bellomo G. LDL oxidation in patients with severe carotid atherosclerosis: a study of in vitro and in vivo oxidation markers. Arterioscler Thromb Vasc Biol. 1994;14:1892-1899.
6. Yla-Herttuala S, Palinski W, Butler SW, Picard S, Steinberg D, Witztum JL. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler Thromb. 1994;14:32-40.
7. Griffith RL, Virella GT, Stevenson HC, Lopes-Virella MF. Low density lipoprotein metabolism by human macrophages activated with low density lipoprotein immune complexes. J Exp Med. 1988;168: 1041-1059.
8. Lopes-Virella MF, Binzafar N, Rackley S, Takei A, LaVia M, Virella G, The uptake of LDL-comaining immune complexes by human macrophages: predominant involvement of the FcγRI receptor. Atherosclerosis. 1997;135:161-170.
9. Huang Y, Ghosh MJ, Lopes-Virella MF. Transcriptional and post-transcriptional regulation of LDL receptor gene expression in PMA-treated THP-1 cells by LDL-containing immune complexes. J Lipid Res. 1997;38:110-120.
10. Libby P. Molecular bases of the acute coronary syndromes. Circulation. 1995;91:2844-2850.
11. Virella G, Munoz JF, Galbraith GM, Gissinger C, Chassereau CH, Lopes-Virella MF. Activation of human monocyte-derived macrophage by immune complexes containing low density lipoprotein. Clin Immunol Immunopathol. 1995;75:179-189.
12. Bevilacqua MP, Pober JS, Majeau GR, Cotran RS, Gimbrone MA Jr. Interleukin 1 induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med. 1984; 160:618-623.
13. Luscinskas FW, Brock AF, Arnaout MA, Grimbone MA. Endothelial-leukocyte adhesion molecule-1-dependent and leukocyte (CD11/CD18)-dependent mechanisms contribute to polymorphonuclear leukocyte adhesion to cytokine-activated human vascular endothelium. J Immunol. 1989;142:2257-2263.
14. Raines EW, Dower SK, Ross R. Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. Science. 1989; 243:393-396.
15. Ravetch JV, Kinet J. Fc receptors. Annu Rev Immunol. 1991;9:457-492.
16. Park RK, Liu Y, Durden DL. A role for She, Grb2, and Raf-1 in FcγRI signal relay. J Biol Chem. 1996;271:13342-13348.
17. Indik ZK, Park JG, Hunter S. Schreiber AD. The molecular dissection of Fc gamma receptor mediated phagocytosis. Blood. 1995;86:4389-4399.
18. Su B, Karin M. Mitogen-activated protein kinase cascade and regulation of gene expression. Curr Opin Immunol. 1996;8:402-411.
19. Geppert TD, Whitehurst CE, Thompson P, Beutler B. Lipopolysaccharide signals activation of tumor necrosis factor biosynthesis through the ras/ raf-1/MEK/MAPK pathway. Mol Med. 1994;1:93-103.
20. Kusuhara M, Chait A, Cader A, Berk BC. Oxidized LDL stimulates mitogen-activated protein kinases in smooth muscle cell and macrophages. Arterioscler Thromb Vasc Biol. 1997;17:141-148.
21. 2+ and phosphorylation. Biochem J. 1995;311:189-195.
22. Aywerx J. The human leukemia cell line THP-1: a multifaceled model for the study of monocyte-macrophage differentiation. Experientia. 1991;47: 22-30.
23. Wang N, Tabas I, Winchester R, Ravalli S, Rabbani LE, Tall A. Interleukin 8 is induced by cholesterol loading of macrophages and expressed by macrophage foam cells in human atheroma. J Biol Chem. 1996;271: 8837-8842.
24. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem. 1957;193:265-275.
25. Dignam JD, Leboritz RM, Roeder RC. Acute transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983;11:1475-1489.
26. Mironova M, Virella G, Lopes-Virella MF. Isolation and characterization of human antioxidized LDL autoantibodies. Arterioscler Thromb Vasc Biol. 1996;16:222-229.
27. Krieger M, Herz J. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptor and LDL receptor-related protein (LRP). Annu Rev Biochem. 1994;63:601-637.
28. Jimi S, Sakata N, Matunaga A, Takebayashi S. Low density lipoproteins bind more to type I and III collagens by negative charge-dependent mechanisms than to type IV and V collagens. Atherosclerosis. 1994;107: 109-116.
29. Greilberger J, Schmut O, Jurgens G. In vitro interactions of oxidatively modified LDL with type I, II, III, IV, and V collagen, laminin, fibronectin, and poly-D-lysine. Arterioscler Thromb Vasc Biol. 1997;17: 2721-2728.
30. Rus HG, Niculescu G, Vlaicu R. Tumor necrosis factor-alpha in human arterial wall with atherosclerosis. Atherosclerosis. 1991;89:247-254.
31. 2. J Immunol. 1995;155:2123-2133.
32. Libby P, Geng YJ, Aikawa M, Schoenbeck U, Mach F, Clinton SK, Sukhova GK, Lee RT. Macrophages and atherosclerotic plaques stability. Curr Opin Lipidol. 1996;7:330-335.
33. Shiratori Y, Okwu AK, Tabas I. Free cholesterol loading of macrophages stimulates phosphatidylcholine biosynthesis and up-regulation of CTP: phosphocholine cytidylyltransferase. J Biol Chem. 1994;269:11337-11348.
34. Kayden HJ, Maschio F, Traber MG. The secretion of apolipoprotein E by human monocyte-derived macrophages. Arch. Biochem. Biophys. 1985;239:388-395.
35. Lesnik P, Rouis M, Skarkatos S, Kruth HS, Chapman MJ. Uptake of exogenous free cholesterol induces upregulation of tissue factor expression in human monocyte-derived macrophages. Proc Natl Acad Sci. U S A. 1992;89:10370-10374.
36. Rouis M, Nigon F, Lafuma C, Hornebeck W, Chapman MJ. Expression of elastase activity by human monocyte-macrophages is modulated by cellular cholesterol content, inflammatory mediators, and phorbol myristate acetate. Arteriosclerosis. 1990;10:246-255.
37. Yla-Herttuala S, Lipton BA, Rosenfeld ME, Sarkioja T, Yoshimura T, Leonard EJ, Witztum JL, Steinberg D. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci. U S A. 1991;88:5252-5256.
38. Casey P. Protein lipidation in cell signaling. Science. 1995;268:221-225.
39. Jerome WG, Cash C, Webber R, Horton R, Yancey PG. Lysosomal lipid accumulation from oxidized low density lipoprotein is correlated with hypertrophy of the Golgi apparatus and trans-Golgi network. J Lipid Res. 1998;39:1362-1371.
40. Smith EB. The influence of age and atherosclerosis on the chemistry of aortic intima: part 2: collagen and mucopolysaccharides. J Atheroscler Res. 1965;5:241-248.
41. Morton LF, Barnes MJ. Collagen polymorphism in the normal and diseased blood vessel wall: investigation of collagens types I, III and V. Aterosclerosis. 1982;42:41-51.
42. Murata K, Motayama T, Kotake C. Collagen type in various layers of the human aorta and their changes with the atherosclerotic process. Atherosclerosis. 1986;60:251-262.
43. Hoover GA, McCormick S, Kalant N. Interaction of native and cell-modified low density lipoprotein with collagen gel. Arteriosclerosis. 1988;8:525-534.
44. Ushio-Fukai M, Alexander RW, Akers M, Griendling KK. p38 mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II: role in vascular smooth muscle cell hypertrophy. J Biol Chem. 1998;273:15022-15029.
45. Clerk A, Fuller SJ, Michael A,'Sugden PH. Stimulation of "stress-regulated" mitogen-activated protein kinases (stress-activated protein kinase/c-Jun N-terminal kinases and p38-mitogen-activated protein kinases) in perfused rat hearts by oxidative and other stress. J Biol Chem. 1998;273:7228-8234.